Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2021 Financial Results
October 15, 2021 16:36 ET
|
Cryo-Cell International, Inc.
OLDSMAR, Fla., Oct. 15, 2021 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (the “Company”), the world’s first private cord blood bank to separate and store...
Insights on the Cell Therapy Consumables Global Market to 2031 - Industry Trends and Forecasts
October 12, 2021 06:53 ET
|
Research and Markets
Dublin, Oct. 12, 2021 (GLOBE NEWSWIRE) -- The "Cell Therapy Consumables Market by Type of Consumable, Type of Cell Therapy, Scale of Operation, Type of End-User and Key Geographical Regions:...
Cryo-Cell International Announces Changes To Its Board of Directors
September 20, 2021 18:05 ET
|
Cryo-Cell International, Inc.
MIAMI, Sept. 20, 2021 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (Nasdaq:CCEL), the leader in cord blood and cord tissue cryopreservation services, announces the appointment of Mr. Mark...
Global Cell Therapy Market Opportunity: USD 45 Billion+ By 2028
September 06, 2021 04:23 ET
|
Research and Markets
Dublin, Sept. 06, 2021 (GLOBE NEWSWIRE) -- The "Global Cell Therapy Market Outlook, Patent & Clinical Trials Insight 2028" report has been added to ResearchAndMarkets.com's offering. In last...
Cryo-Cell International Announces Uplisting to The Nasdaq Capital Market
August 30, 2021 09:00 ET
|
Cryo-Cell International, Inc.
Cryo-Cell International, Inc. (Symbol CCEL), The Leader In Cord Blood And Cord Tissue Cryopreservation Services, Today Announced That The Company’s Common Stock Has Been Approved For Listing On The...
Rubius Therapeutics Appoints Jim Jogerst as Chief Business Officer
August 30, 2021 08:00 ET
|
Rubius Therapeutics
CAMBRIDGE Mass., Aug. 30, 2021 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq: RUBY), a clinical-stage biopharmaceutical company that is genetically engineering red blood cells to create an...
Cryo-Cell International Completes Acquisition of Real Estate Property for Its Institute for Cellular Therapies
August 20, 2021 09:04 ET
|
Cryo-Cell International, Inc.
Cryo-Cell International (symbol: CCEL) Purchases Real Estate Location for its Institute for Cellular Therapies in the Raleigh-Durham area. MIAMI, Aug. 20, 2021 (GLOBE NEWSWIRE) -- Cryo-Cell...
Cryo-Cell International to Present at the Q3 Virtual Investor Summit
August 11, 2021 09:00 ET
|
Cryo-Cell International, Inc.
MIAMI, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Cryo-Cell International announces that Chairman of the Board and Co-CEO, David Portnoy, will be presenting at the Q3 Virtual Investor Summit on August 18th,...
Outlook on the Cell Therapy Manufacturing Global Market to 2030 - Industry Trends and Forecasts
August 11, 2021 07:48 ET
|
Research and Markets
Dublin, Aug. 11, 2021 (GLOBE NEWSWIRE) -- The "Cell Therapy Manufacturing Market by Type of Cell Manufactured, Source of Cell, Scale of Operation, Purpose of Manufacturing and Key Geographical...
Asia-Pacific Cell Therapy Market Analysis 2021-2028 - Need for Development of New Therapies Against SARS-CoV-2 Presents Lucrative Opportunities
August 04, 2021 10:13 ET
|
Research and Markets
Dublin, Aug. 04, 2021 (GLOBE NEWSWIRE) -- The "Asia Pacific Cell Therapy Market Size, Share & Trends Analysis Report by Use-type (Clinical-use, Research-use), by Therapy Type (Autologous,...